Since persistent activation of STAT3 is oncogenic and is prevalent in a wide variety of human cancers, such as CRC (Xiong et al., 2012), we focused on the JAK2/STAT3 pathway. This evidence concerns the gene STAT3 and colorectal carcinoma.